New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 16, 2014
04:55 EDTLPCN, LPCNLipocine management to meet with Jefferies
Meeting to be held in New York on July 23 hosted by Jefferies.
News For LPCN From The Last 14 Days
Check below for free stories on LPCN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
06:59 EDTLPCNLipocine trading halted, pending news
Subscribe for More Information
September 8, 2014
16:01 EDTLPCNLipocine announces first patient dosed in LPCN 1107 Phase 1 study
Lipocine announced the first patient was dosed in a Phase 1 study in pregnant women of LPCN 1107, the company's oral hydroxyprogesterone caproate, or HPC, product candidate. The primary objectives of the study will be to determine safety, tolerability and pharmacokinetics of oral administration of LPCN 1107 in pregnant subjects. Previously in Phase 1 clinical testing, LPCN 1107 was well tolerated and achieved meaningful drug levels after oral administration in healthy, non-pregnant women.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use